SALVATI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.638
AS - Asia 1.883
EU - Europa 1.858
SA - Sud America 237
AF - Africa 51
OC - Oceania 16
Totale 6.683
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.584
RU - Federazione Russa 803
SG - Singapore 525
CN - Cina 507
IT - Italia 470
HK - Hong Kong 256
BR - Brasile 173
VN - Vietnam 173
KR - Corea 148
IE - Irlanda 108
SE - Svezia 91
DE - Germania 87
FR - Francia 86
FI - Finlandia 81
IN - India 58
GB - Regno Unito 48
BD - Bangladesh 40
JO - Giordania 39
ID - Indonesia 35
CA - Canada 30
JP - Giappone 27
AR - Argentina 25
CH - Svizzera 17
MX - Messico 17
AU - Australia 15
PL - Polonia 15
NL - Olanda 14
ZA - Sudafrica 14
EC - Ecuador 13
IQ - Iraq 13
TR - Turchia 10
ES - Italia 8
NG - Nigeria 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
PK - Pakistan 7
CI - Costa d'Avorio 6
PY - Paraguay 6
TW - Taiwan 6
UA - Ucraina 6
EG - Egitto 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
MA - Marocco 4
PE - Perù 4
AL - Albania 3
BJ - Benin 3
BO - Bolivia 3
GR - Grecia 3
LT - Lituania 3
TN - Tunisia 3
UZ - Uzbekistan 3
AT - Austria 2
BH - Bahrain 2
CG - Congo 2
HU - Ungheria 2
KG - Kirghizistan 2
MM - Myanmar 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
SN - Senegal 2
UG - Uganda 2
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
BT - Bhutan 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.683
Salva come PNG Salva come JPEG
Città #
Santa Clara 522
Ashburn 505
Singapore 392
Hong Kong 222
San Jose 204
Seoul 145
Hefei 134
Dublin 108
Fairfield 91
Chandler 83
Florence 79
Beijing 65
Milan 64
Moscow 64
Ho Chi Minh City 62
Council Bluffs 57
Los Angeles 57
Dallas 56
New York 52
Munich 49
Buffalo 47
Helsinki 45
Houston 44
Woodbridge 44
Hanoi 38
Cambridge 37
Rome 37
Lauterbourg 35
Wilmington 34
Mumbai 31
The Dalles 30
Altamura 28
Lawrence 28
Jakarta 27
Kent 25
São Paulo 25
Seattle 24
Paris 22
Princeton 20
Turku 20
London 19
Tokyo 19
Washington 19
Shanghai 18
Boston 16
Orem 16
Siena 16
Lappeenranta 15
Bern 14
Warsaw 14
Frankfurt am Main 13
Medford 12
Melbourne 12
Bengaluru 10
Bologna 10
Montreal 10
San Diego 10
Toronto 10
Chicago 9
Denver 9
Oristano 9
Yubileyny 9
Abuja 8
Ann Arbor 7
Baghdad 7
Biên Hòa 7
Figino 7
Guangzhou 7
Johannesburg 7
Rio de Janeiro 7
Xi'an 7
Abidjan 6
Boardman 6
Brooklyn 6
Da Nang 6
Sant'elpidio A Mare 6
West Jordan 6
Atlanta 5
Bari 5
Buenos Aires 5
Düsseldorf 5
Haiphong 5
Norwalk 5
Redondo Beach 5
Tianjin 5
Amman 4
Ankara 4
Brasília 4
Campi Bisenzio 4
Cape Town 4
Changsha 4
Guayaquil 4
Hillsboro 4
Hải Dương 4
Manchester 4
Mexico City 4
Miano 4
Naples 4
Napoli 4
Phoenix 4
Totale 4.141
Salva come PNG Salva come JPEG
Nome #
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 265
The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study 239
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients 231
Clinical and dermoscopic features of lichenoid keratosis: A retrospective case study 197
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients 195
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron 187
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 186
A clinical, pathological and immunohistochemical series of 9 cases of primary cutaneous apocrine carcinomas of the head and neck 185
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 184
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients 182
Clinical and Dermoscopic Features of Vulvar Melanosis over the Last 20 Years 182
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization 180
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab 177
Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients 172
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab 170
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 167
From Emollients to Biologicals: Targeting Atopic Dermatitis 166
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals 162
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies 162
Presentation and progression of MPO-ANCA interstitial lung disease 160
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection 160
Active monitoring of long-term immunity to SARS-CoV-2 infection and vaccination 157
Spectrum of Fibrotic Lung Diseases 157
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis 152
Disseminated nocardiosis and anti-GM-CSF antibodies 146
A gendered magnifying glass on COVID-19 144
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH) 143
“Adrenaline junkie”: a case report of repeated use of epinephrine 140
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 136
Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature 135
A gender-specific approach to occupational allergic contact dermatitis 135
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 128
Alarming inflammation: The TGFβ1–Nrp1 pathway upregulates the IL-33 axis in lung ILC2s 125
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 122
Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: a first case report 121
Late initiation of anakinra can induce complete renal response in renal AA amyloidosis secondary to Familial Mediterranean Fever. 119
Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis 116
Therapeutical Targets in Allergic Inflammation 101
Melanoma brain metastases: review of histopathological features and immune-molecular aspects 98
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion 96
Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization: An Italian cohort study 92
Gender differences in anaphylaxis 92
Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthma 91
5-ALA Assisted Surgery of Human Glioblastoma Samples Reveals an Enrichment of T Cells Expressing PD-1 and CD103 in the Intermediate and Marginal Layers 84
Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated 12
Modulation of type 2 inflammation during grass pollen-specific sublingual immunotherapy 9
Totale 6.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022178 7 17 7 5 11 17 5 12 11 7 30 49
2022/2023517 36 99 29 26 25 84 68 29 66 11 23 21
2023/2024387 7 26 49 21 27 63 10 69 8 53 34 20
2024/20252.150 70 218 108 337 499 230 83 136 132 77 113 147
2025/20263.225 376 396 337 319 341 109 409 137 191 204 151 255
2026/20274 4 0 0 0 0 0 0 0 0 0 0 0
Totale 6.760